AuB
AuB is an intestinal microflora analysis that contributes to the athlete's performance improvement and human health maintenance.
Launch date
Market cap
-
Enterprise valuation
AUD17—26m (Dealroom.co estimates Sep 2019.)
Tokyo Japan (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$310k | Seed | ||
| N/A | JPY55.0m | Series A | |
| N/A | JPY8.0m | Series A | |
$2.8m | Series A | ||
$2.3m | Late VC | ||
| Total Funding | AUD9.2m | ||
Recent News about AuB
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.